| Zugriffe | |
|---|---|
| Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis | 395 |
| Juni 2025 | Juli 2025 | August 2025 | September 2025 | Oktober 2025 | November 2025 | Dezember 2025 | |
|---|---|---|---|---|---|---|---|
| Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis | 1 | 4 | 6 | 11 | 26 | 23 | 5 |
| Zugriffe | |
|---|---|
| 1065.full.pdf | 221 |
